Gilead Sciences to Present at Two Upcoming Investor Conferences
June 09 2010 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the William Blair 30th Annual Growth
Stock Conference in Chicago and the Goldman Sachs 31st Annual
Global Healthcare Conference in Los Angeles.
Robin Washington, Gilead’s Senior Vice President and Chief
Financial Officer, will provide an overview of the company at the
William Blair conference on Wednesday, June 16 at 1:20 p.m. CDT
(2:20 p.m. EDT).
John F. Milligan, PhD, Gilead’s President and Chief Operating
Officer, will provide an overview of the company at the Goldman
Sachs conference on Wednesday, June 16 at 1:20 p.m. PDT (4:20 p.m.
EDT).
To access the live webcasts via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15
minutes prior to each live presentation to ensure adequate time for
any software download that may be necessary to listen to the
webcast.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company's mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead
Sciences, please visit www.gilead.com orcall the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024